@article{21367ef5b3cf439fae2452e63147d73e,
title = "A human organotypic microfluidic tumor model permits investigation of the interplay between patient-derived fibroblasts and breast cancer cells",
abstract = "Tumor-stroma interactions significantly influence cancer cell metastasis and disease progression. These interactions are partly comprised of the cross-talk between tumor and stromal fibroblasts, but the key molecular mechanisms within the cross-talk that govern cancer invasion are still unclear. Here, we adapted our previously developed microfluidic device as a 3Din vitro organotypic model to mechanistically study tumor- stroma interactions by mimicking the spatial organization of the tumor microenvironment on a chip. We cocultured breast cancer and patient-derived fibroblast cells in 3D tumor and stroma regions, respectively, and combined functional assessments, including cancer cell migration, with transcriptome profiling to unveil the molecular influence of tumor-stroma cross-talk on invasion. This led to the observation that cancerassociated fibroblasts (CAF) enhanced invasion in 3D by inducing expression of a novel gene of interest, glycoprotein nonmetastatic B (GPNMB), in breast cancer cells, resulting in increased migration speed. Importantly, knockdown of GPNMB blunted the influence of CAF on enhanced cancer invasion. Overall, these results demonstrate the ability of our model to recapitulate patient-specific tumor microenvironments to investigate the cellular and molecular consequences of tumor-stroma interactions. Significance: An organotypic model of tumor-stroma interactions on a microfluidic chip reveals that CAFs promote invasion by enhancing expression of GPNMB in breast cancer cells.",
author = "Truong, {Danh D.} and Alexander Kratz and Park, {Jin G.} and Barrientos, {Eric S.} and Harpinder Saini and Toan Nguyen and Barbara Pockaj and Ghassan Mouneimne and Joshua LaBaer and Mehdi Nikkhah",
note = "Funding Information: We would like to acknowledge National Science Foundation Award # CBET 1510700 received by M. Nikkhah, the National Institutes of Health R01CA196885 received by G. Mouneimne, funding from Breast Cancer Research Foundation received by J. LaBaer and J.G. Park, the 2017–2018 Achievement Rewards for College Scientists Scholarship received by D.D. Truong, the 2016–2017 and 2017–2018 International Foundation for Ethical Research Fellowship received by D.D. Truong, and funding from ASU Graduate & Professional Student Association and the ASU Graduate College received by D.D. Truong. We also acknowledge Ali Navaei for his input in scientific discussions, Zachary Camacho for his help on microfluidic fabrication, Jaime-son Veldhuizen for her assistance on wafer fabrication, Padhmavathy Yuvaraj and Ian Shoemaker for assistance on Western blot imaging, Crystal Willingham for assistance on RNA isolation, Kassondra Hickey for qPCR protocols, and the Smith and Stabenfeldt laboratory at ASU for equipment usage. Plasmids were obtained from DNASU and Addgene plasmid repositories. Finally, anti-BrdU was purchased from the Developmental Studies Hybridoma Bank, deposited to the DSHB by S.J. Kaufman, and maintained at The University of Iowa, Department of Biology, Iowa City, IA. Publisher Copyright: {\textcopyright} 2019 American Association for Cancer Research.",
year = "2019",
month = jun,
day = "15",
doi = "10.1158/0008-5472.CAN-18-2293",
language = "English (US)",
volume = "79",
pages = "3139--3151",
journal = "Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "12",
}